93117-86-3

Upstream product

• 88150-42-9 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine 
• 10191-60-3 dimethyl N-cyanodithioiminocarbonate 

Downstream Products

• 93848-91-0 1-<2-<<4-(2-chlorophenyl)-3-(ethoxycarbonyl)-5-(methoxycarbonyl)-6-methyl-1,4-dihydropyrid-2-yl>methoxy>ethyl>-2-cyano-3-<2-(dimethylamino)ethyl>guanidine 
• 93848-86-3 1-<2-<<4-(2-chlorophenyl)-3-(ethoxycarbonyl)-5-(methoxycarbonyl)-6-methyl-1,4-dihydropyrid-2-yl>methoxy>ethyl>-2-cyano-3-methylguanidine 
• 93118-75-3 2-<<2-<(3-Amino-1H-1,2,4-triazol-5-yl)amino>ethoxy>methyl>-4-(2-chlorophenyl)-3-(ethoxycarbonyl)-5-(methoxycarbonyl)-6-methyl-1,4-dihydropyridine 

Relevant academic research and scientific papers

Long Acting Dihydropyridine Calcium Antagonists. 2. 2-methyl Derivatives

A series of dihydropyridines were prepared as selective coronary vasodilators.Results showed that a wide variety of five- and six-membered heterocycles were acceptable at the 2-position of the dihydropyridine ring and in

Dihydropyridines

Dihydropyridine anti-ischaemic agents of the formula: STR1 and their salts where R is aryl or heteroaryl, R1 and R2 are each C1 -C4 alkyl or 2-methoxyethyl, Y is --(CH2)n -- where n is 2, 3, or 4 and is optionally substituted by 1 or 2 CH3 groups, and R3 is an optionally substituted 5- or 6-membered heterocyclic group attached to the adjacent N atom by a C atom, said group R3 being optionally fused to a further heterocyclic group or to a benzene ring.